Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.
Voriconazole is a new antifungal agent that can be given orally and intravenously. It has proven efficacy for treating candidosis and invasive aspergillosis as well as other mould infections, such as those caused by Fusarium and Scedosporium spp. The drug is generally well tolerated.
Donnelly
J P
JP
Department of Haematology, University Medical Center St Radboud, Nijmegen, The Netherlands. p.donnelly@usa.net
De Pauw
B E
BE
D000935:Antifungal Agents / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D011743:Pyrimidines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014230:Triazoles / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole